Development of a screening system for DNA damage and repair of potential carcinogens based on dual luciferase assay in human HepG2 cell-Reference-Cited by-同舟云学术

Development of a screening system for DNA damage and repair of potential carcinogens based on dual luciferase assay in human HepG2 cell

Published:2013-06-22 Issue:5 Volume:28 Page:515-524
ISSN:1464-3804
Container-title:Mutagenesis
language:en
Short-container-title:

Author:

Fan Longgang,Niu Yujie,Zhang Shaohui,Shi Lei,Guo Huicai,Liu Yi,Zhang Rong

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Genetics (clinical),Toxicology,Genetics

Link

http://academic.oup.com/mutage/article-pdf/28/5/515/12914743/get028.pdf

Reference65 articles.

1. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair;Harris;Carcinogenesis,1989

2. DNA repair as a biomarker;Collins;Mutat. Res.,2012

3. The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors;Møller;Cancer Epidemiol. Biomarkers Prev.,2000

4. Chromosomal aberration, micronucleus and Comet assays on peripheral blood lymphocytes of leprosy patients undergoing multidrug treatment;Kalaiselvi;Mutagenesis,2002

5. Association of chromosome damage detected as micronuclei with hematological diseases and micronutrient status;Lal;Mutagenesis,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic instability of lung induced by carbon black nanoparticles is related with Plk1 signals changes;NanoImpact;2022-04

3. Reduction of oxidative damages induced by titanium dioxide nanoparticles correlates with induction of the Nrf2 pathway by GSPE supplementation in mice;Chemico-Biological Interactions;2017-09

4. Reduction of DNA damage induced by titanium dioxide nanoparticles through Nrf2 in vitro and in vivo;Journal of Hazardous Materials;2015-11

5. Nucleotide excision repair: Why is it not used to predict response to platinum-based chemotherapy?;Cancer Letters;2014-05